GSK - GlaxoSmithKline plc

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 599.56B
Enterprise Value 399.43B
Trailing P/E 40.51
Forward P/E 113.18
PEG Ratio (5 yr expected) 11.32
Price/Sales (ttm)N/A
Price/Book (mrq)16.70
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 0.55
52-Week Change 3-3.31%
S&P500 52-Week Change 3-0.33%
52 Week High 342.47
52 Week Low 336.41
50-Day Moving Average 340.91
200-Day Moving Average 340.45

Share Statistics

Avg Vol (3 month) 32.34M
Avg Vol (10 day) 32.23M
Shares Outstanding 52.49B
Float 2.44B
% Held by Insiders 10.01%
% Held by Institutions 111.00%
Shares Short (Jul 31, 2019) 46.33M
Short Ratio (Jul 31, 2019) 42.39
Short % of Float (Jul 31, 2019) 4N/A
Short % of Shares Outstanding (Jul 31, 2019) 40.24%
Shares Short (prior month Jun 28, 2019) 46.43M

Dividends & Splits

Forward Annual Dividend Rate 41.86
Forward Annual Dividend Yield 44.65%
Trailing Annual Dividend Rate 31.06
Trailing Annual Dividend Yield 32.65%
5 Year Average Dividend Yield 45.46
Payout Ratio 489.37%
Dividend Date 3Oct 10, 2019
Ex-Dividend Date 4Aug 8, 2019
Last Split Factor (new per old) 21/2
Last Split Date 3Nov 12, 1991

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 13.94%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)8.03%
Return on Equity (ttm)161.84%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)6.80%
Gross Profit (ttm)21.11B
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)0.99
Quarterly Earnings Growth (yoy)118.60%

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)1,127.74
Current Ratio (mrq)0.71
Book Value Per Share (mrq)2.41

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A